Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma

NCT01418729 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocarcinoma

Interventions

DRUG: Pravastatin

Sponsor

Hospital Donostia

Collaborators

[object Object]